Somatostatin and Cognitive Function in Neurodegenerative Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|13|1|34-46

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.13, Iss.1, 2013-01, pp. : 34-46

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lysine Acetyltransferases CBP and p300 as Therapeutic Targets in Cognitive and Neurodegenerative Disorders

By  

Current Pharmaceutical Design, Vol. 19, Iss. 28, 2013-04 ,pp. : 5051-5064

Bentham Science Publishers

Access to resources Recommend Favorite

Antioxidants as treatment for neurodegenerative disorders

By Moosmann Bernd   Behl Christian  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 10, 2002-10 ,pp. : 1407-1435

Informa Healthcare

Access to resources Recommend Favorite

Targeting TRPs in Neurodegenerative Disorders

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 3, 2013-02 ,pp. : 322-334

Bentham Science Publishers

Access to resources Recommend Favorite

Peptide Therapeutics in Neurodegenerative Disorders

By  

Current Medicinal Chemistry, Vol. 21, Iss. 23, 2014-08 ,pp. : 2610-2631

Bentham Science Publishers

Access to resources Recommend Favorite

Oxysterol Derivatives of Cholesterol in Neurodegenerative Disorders

By  

Current Medicinal Chemistry, Vol. 18, Iss. 10, 2011-04 ,pp. : 1515-1525

Bentham Science Publishers

Access to resources Recommend Favorite